These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27531117)

  • 1. [The prospects of the biotherapy for refractory uveitis].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):551-6. PubMed ID: 27531117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of biologics for the treatment of noninfectious uveitis.
    Takeuchi M
    Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic agents in experimental autoimmune uveitis.
    Giuliari GP; Sadaka A; Hinkle DM
    Int Ophthalmol; 2014 Feb; 34(1):145-56. PubMed ID: 23494482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
    Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):687-698. PubMed ID: 29610003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Immunosuppressive Therapies in Uveitis Treatment.
    Mérida S; Palacios E; Navea A; Bosch-Morell F
    Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of immunosuppressive drug therapy in uveitis.
    Dunn JP
    Curr Opin Ophthalmol; 2004 Aug; 15(4):293-8. PubMed ID: 15232467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biologics in uveitis].
    Feurer E; Bielefeld P; Saadoun D; Sève P
    Rev Med Interne; 2015 Feb; 36(2):107-16. PubMed ID: 25239400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
    Pleyer U; Pohlmann D; Stübiger N
    Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert opinion on the use of biological therapy in non-infectious uveitis.
    Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
    Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
    Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
    Heiligenhaus A; Tappeiner C; Walscheid K; Heinz C
    Ophthalmologe; 2016 May; 113(5):391-7. PubMed ID: 27142035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics in the Treatment of Uveitis.
    Dingerkus VLS; Becker MD; Doycheva D
    Klin Monbl Augenheilkd; 2022 May; 239(5):686-694. PubMed ID: 35426112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile.
    Neri P; Arapi I; Nicolai M; Pirani V; Saitta A; Luchetti MM; Giovannini A; Mariotti C
    Curr Drug Saf; 2016; 11(1):47-54. PubMed ID: 26463249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and effects of biological agents in the treatment of noninfectious uveitis.
    Li B; Yang L; Bai F; Tong B; Liu X
    Immunotherapy; 2022 Aug; 14(12):985-994. PubMed ID: 35695019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor-α therapy in uveitis.
    Cordero-Coma M; Sobrin L
    Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TNFalpha inhibitors in the treatment of uveitis].
    Greiner K; Plskova J
    Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy.
    Egwuagu CE; Yu CR; Li Z; Nussenblatt RB
    J Autoimmun; 2005 Feb; 24(1):39-46. PubMed ID: 15725575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil use in the treatment of noninfectious uveitis.
    Klisovic DD
    Dev Ophthalmol; 2012; 51():57-62. PubMed ID: 22517204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.